Blog - Page 3114 of 5753

FridayApr 12, 2013 9:39 am

International Stem Cell Corp. (ISCO) Scores Major Goal with Parkinson’s Disease Treatment

International Stem Cell Corp. has scored a major goal in the use of stem cells for the treatment of Parkinson’s disease. Parkinson’s is a debilitating disorder, involving a progressive degeneration of dopamine producing neurons in the central nervous system. Traditional treatments simply attempt to replace the lost dopamine, which can help at first but, as symptoms grow worse, its efficacy declines, leaving many patients severely disabled. In a recent study, positive animal data reported by ISCO has established that Parkinson’s symptoms can be successfully treated with the company’s unique parthenogenetic stem cell derived neuronal cells, a huge accomplishment. Previous moves…

FridayApr 12, 2013 8:29 am

World Energy Solutions, Inc. (XWES) Procures Huge Electric Savings for Abilene Independent School District

World Energy Solutions, a leading energy management services firm and approved energy services provider in the TIPS/TAPS purchasing program, today announced that the company has successfully procured over 62 million kWh of electricity for Abilene Independent School District (AISD), a public school district serving over 17,000 students in Abilene and Impact, Texas. Abilene ISD was able to test market prices for various electricity terms and products in an efficient and transparent manner through a series of online auctions run on the World Energy Exchange®. The competitive event attracted twelve suppliers overall, who submitted more than 120 bids fir AISD's business…

FridayApr 12, 2013 8:26 am

StemCells, Inc. (STEM) Reaches Agreement for $19.3 Million in Funding from California Institute for Regenerative Medicine to Help Fund IND for Alzheimer’s Disease

StemCells, a company engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery, announced that it has reached an agreement with the California Institute for Regenerative Medicine (CIRM) for CIRM to extend approximately $19.3 million in funding for preclinical development and IND-enabling activities of the company’s proprietary HuCNS-SC® product candidate (purified human neural stem cells) for Alzheimer’s disease. The funding will be granted in the form of a forgivable loan and was awarded within CIRM’s Disease Team Therapy Development Award program (RFA 10-05) in September 2012. The research is…

ThursdayApr 11, 2013 4:13 pm

SmallCapVoice: SANUWAVE Health, Inc. (SNWV) Receives U.S. Patent to Sterilize Blood Using Its Shock Wave Technology

SANUWAVE Health has received a patent issued by the U.S. Patent and Trademark Office entitled “Method and Devices for Cleaning and Sterilization with Shock Waves.” The claims of the patent (patent number 8,343,420) relate to a new method that sterilizes blood by applying external shock waves to destroy blood pathogens contained in bags, pipes and tubes. The patent has a term extending to July 2031. “This marks the first of many patents that we intend to add to our intellectual property portfolio to broaden the use of our technology beyond wound care and regenerative medicine,” commented Joseph Chiarelli, Chief Executive…

ThursdayApr 11, 2013 4:03 pm

Trans-Pacific Aerospace Company, Inc. (TPAC) Extends China Footprint with Acquisition of 55% Ownership Stake in Godfrey (China) Ltd.

Trans-Pacific Aerospace Company, a designer, engineer, and manufacturer of self-lubricating spherical bearings for commercial aircrafts, has acquired a 55 percent stake in Godfrey (China) Ltd., a Hong Kong corporation. The acquisition is in line with Trans-Pacific’s mission to tap into the Chinese market, which is the world’s largest aviation market outside of the United States. The Aviation Industry Corporation of China (AVIC) projects that the country’s commercial aircraft fleet will more than triple by 2031 vs. the number of aircrafts in 2011. "We're very pleased with our majority stake acquisition," Trans-Pacific CEO Bill McKay stated in the press release. "The…

ThursdayApr 11, 2013 4:00 pm

First Titan Corp. (FTTN) Doubles Down on Growth Strategy, Enters Talks to Acquire 1k Texas Gulf Coast Acres

First Titan is aggressively adding to an already impressive portfolio of domestic hydrocarbon assets (Alabama, Louisiana, Oklahoma, and Texas), with the report of yet another strategic coup today, as news comes out that the company is elbow-deep in negotiations to acquire some 1k acres in prime Texas Gulf Coast territory. This deal would tack on some serious acreage to FTTN's Texas operations, currently consisting of some 640 net acres in Terrell County (West Texas), known as the Big Canyon Prospect. The target properties currently being negotiated for contain both producing assets and considerable development upside, giving FTTN a nice break-out…

ThursdayApr 11, 2013 3:52 pm

Pluristem Therapeutics, Inc. (PSTI) Licensee Gets Regulatory Approval to Begin Phase I Study of PLX-PAD Cells

Pluristem Therapeutics is a leading developer of placenta-based cell therapies. The company's patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to a host of local and systemic inflammatory and ishemic diseases. The cells are grown using the company's proprietary 3D micro-environmental technology. The company today announced that following favorable pre-clinical studies, biotechnology firm United Therapeutics Corp. received approval to perform a human Phase 1 study in Australia using Pluristem's PLX-PAD cells in patients that have been diagnosed with pulmonary arterial hypertension (PAH). This disease is characterized by abnormally high…

ThursdayApr 11, 2013 9:01 am

Myriad Interactive Media, Inc. (MYRY) Establishes Entrance into European Market, Provides Mingle Suite Update

Myriad Interactive Media, an interactive media and development company in Canada, has expanded its global footprint to include Copenhagen, Denmark, where the company will sell Myriad and Mingle Suite technologies to the European market through a partnership with Opello Group ApS. "We are delighted to announce that we have signed a joint-venture agreement with Opello Group ApS. Opello will manage the 'Myriad' brand in Denmark," Derek Ivany, CEO of Myriad stated in the press release. "We have put together a strategic plan to expand our business to Europe and begin selling our Mingle Suite social media technology and Web site…

ThursdayApr 11, 2013 8:41 am

Autobytel Inc. (ABTL) Rolls Out Dealer of the Month Award

Autobytel, a company dedicated to helping automotive consumers and dealers connect online, has rolled out a brand new Dealer of the Month award program. The company chose Patti Scipione, Manager of M’Lady Nissan of Crystal Lake, Illinois, as its first-ever recipient for the month of March 2013. Autobytel’s President and CEO, Jeffrey Coats, said, "Patti and the M’Lady Nissan team represent the best in online automotive sales and service. The benchmarks Autobytel created in 1995 when it pioneered the automotive Internet serve as the foundation upon which this entire industry operates today. Our longstanding history enables us to identify exceptional…

ThursdayApr 11, 2013 8:26 am

BG Medicine, Inc. (BGMD) Receives News of CE Mark for Galectin-3 Test

BG Medicine has received news that its partner Abbott, a global leader in in vitro diagnostics, has obtained a CE Mark for the Galectin-3 assay run on the ARCHITECT immunochemistry platform. Pending country registration, this launch of the ARCHITECT Galectin-3 test under the CE Mark will make galectin-3 testing further available in several European countries – another significant step in BG Medicine’s commercial strategy. The progress made by Abbott will expand the use of galectin-3 testing in heart failure patients and strengthen BG Medicine’s ability to drive the growth of galectin-3 testing throughout the world. BG Medicine is currently partnering…

Site Search

Company Search